STAT4 and rheumatoid arthritis: This discrepancy likely reflects the different methodological approaches: while stimulation assays evaluate the transient activation capacity of the JAK/STAT pathway [47], our design aimed to characterize basal (non-stimulated) STAT4 phosphorylation in RA patients under different DMARD therapies.